Chitosan, a naturally occurring polysaccharide derived from chitin, has demonstrated significant potential as an antiviral ...

The study explores the potential of chitosan derivatives as novel inhibitors against the wild-type and emerging variants of ...

SARS-CoV-2 binds to the human cell receptor angiotensin-converting enzyme 2 (ACE2) through its receptor-binding domain in the S1 subunit of the spike protein (S1-RBD). The serum levels of ...

Notably, IL-1β inhibited various SARS-CoV-2 variants and other beta-coronaviruses spike-induced cell-cell fusion ... 10 μL rhotekin-RBD beads were mixed with 600 µg total protein, then the tubes were ...

Non-active site mutations such as L50F are crucial for restoring the viral fitness of SARS-CoV-2 main protease. Here, the authors use full-length Mpro protein as substrate and demonstrate that ...

The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

For decades, lab-made antibodies have been used to support patients fighting specific diseases. These treatments have become ...

Trump has shut down the USAID work saying that it was not aligned with American strategic interests and wastes money.

An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...

UNIGE scientists have developed a groundbreaking technology that creates synthetic molecules mimicking antibodies, potentially revolutionizing disease treatments.

On the eve of Donald Trump's inauguration, the US Department of Health banned the financing and activities of the EcoHealth ...